Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer’s patients in long-term care health facilities

BACKGROUND: Cholinesterase inhibitors can delay the progression of Alzheimer’s disease (AD). Several clinical trials of the drug in moderate to severe AD have consistently reported clinically positive effects. A combining effect with psychosocial intervention was reported in mild to moderate AD pati...

Full description

Saved in:
Bibliographic Details
Published in:BMC Neurol
Main Authors: Meguro, Kenichi, Ouchi, Yoshitaka, Akanuma, Kyoko, Meguro, Mitsue, Kasai, Mari
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4280048/
https://ncbi.nlm.nih.gov/pubmed/25516360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-014-0243-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items